Creatine in Health and Disease
Open accessThe DOI matches its Crossref record; 334 of the 337 references it cites were found in a registry or an index; 66 of the 329 sources its claims cite were checked for support.
Abstract
Although creatine has been mostly studied as an ergogenic aid for exercise, training, and sport, several health and potential therapeutic benefits have been reported. This is because creatine plays a critical role in cellular metabolism, particularly during metabolically stressed states, and limitations in the ability to transport and/or store creatine can impair metabolism. Moreover, increasing availability of creatine in tissue may enhance cellular metabolism and thereby lessen the severity of injury and/or disease conditions, particularly when oxygen availability is compromised. This systematic review assesses the peer-reviewed scientific and medical evidence related to creatine’s role in promoting general health as we age and how creatine supplementation has been used as a nutritional strategy to help individuals recover from injury and/or manage chronic disease. Additionally, it provides reasonable conclusions about the role of creatine on health and disease based on current scientific evidence. Based on this analysis, it can be concluded that creatine supplementation has several health and therapeutic benefits throughout the lifespan.
Overview
CoChat Summary
TL;DR
This systematic review concludes that creatine monohydrate supplementation has health and therapeutic benefits beyond exercise, including support for aging muscle/bone, cognition, glucose management, neuroprotection, rehabilitation, and several clinical conditions. It reports that evidence is promising in many areas but remains limited or equivocal in some populations, especially neurodegenerative disease and pregnancy.
Key findings
- Creatine supplementation increases muscle creatine/phosphocreatine and generally improves high-intensity exercise performance by 10–20%; the International Society of Sports Nutrition calls it “the most effective ergogenic nutritional supplement currently available to athletes.” Reported health effects include lowering cholesterol/triglycerides, antioxidant effects, enhanced glycemic control, increased strength and muscle mass, minimized bone loss in some studies, and improved cognitive function, particularly in older populations.
- In older adults, creatine combined with resistance training promotes greater gains in muscle mass and strength. Examples include 5 g/day for 14 weeks, 0.3 g/kg/day for 5 days plus 0.07 g/kg/day for 79 days, and 0.1 g/kg/day for 12 months increasing strength and bone density in postmenopausal women; meta-analyses support greater muscle mass, strength, and functional capacity.
- In creatine synthesis deficiencies, long-term high-dose creatine (e.g., 0.3–0.8 g/kg/day) increases brain creatine/phosphocreatine and improves or stabilizes clinical symptoms; in 48 children with GAMT deficiency, four treated younger than nine months had normal or almost normal developmental outcomes. Animal neuroprotection studies report 25% reduction in brain damage, 40% decrease in infarction size, and 36% (rats)/50% (mice) reduction in cortical damage after traumatic brain injury.
- A large trial of 1687 participants taking 9.5 g/day for up to 5 years found no statistically significant improvement in Parkinson’s disease or ALS outcomes, though there was some evidence of attenuated brain atrophy in Huntington’s disease. In type 2 diabetes, 5 g/day for 12 weeks improved glucose tolerance, increased GLUT-4 translocation, and reduced HbA1c; in bipolar depression, 6 g/day for 6 weeks produced 66.7% MADRS remission versus 18.2% with placebo.
Methods
- The paper describes a systematic review of scientific and medical literature using keyword searches on creatine supplementation for each topic via PubMed.gov; a total of 1322 articles were reviewed, with relevant research highlighted.
- The review is a narrative synthesis across metabolic role, general health, aging, and therapeutic areas; no meta-analytic pooling, formal inclusion/exclusion criteria, or risk-of-bias assessment is described in the text.
Limitations
- The paper states that additional research is needed, that not all studies show benefit, that efficacy of long-term high-dose creatine in neurodegenerative diseases is equivocal, and that human pregnancy data are limited so caution should be exercised when recommending use during pregnancy.
- The text makes evident that many therapeutic conclusions rely on animal models or small/open-label human studies, and that the majority of ergogenic studies have been conducted on men.
- The review does not report search dates, formal inclusion/exclusion criteria, or quality assessment methods, which limits reproducibility and certainty of the systematic review process.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
26 Valid · 1 Not valid · 49 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Creatine enters the cytosol through creatine transporters (CRTR) [58,59,60,61].”
§ Creatine in Health and Disease > 3. Metabolic Role
What the sources say
- Not checked yetcites [58] Tarnopolsky M.A. Parshad A. Walzel B. Schlattner U. Wallimann T. Creatine transporter and mitochondrial creatine kinase protein content in myopathies Muscle Nerve 2001 24 682 688 10.1002/mus.1055 11317279 source
- Not checked yetcites [59] Santacruz L. Jacobs D.O. Structural correlates of the creatine transporter function regulation: The undiscovered country Amino Acids 2016 48 2049 2055 10.1007/s00726-016-2206-3 26951207 source
- Supportedcites [60] Braissant O. Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers J. Inherit. Metab. Dis. 2012 35 655 664 10.1007/s10545-011-9433-2 22252611 source
The Introduction states that creatine is taken up by cells through a specific creatine transporter, SLC6A8, and explicitly lists CRTR as another name for it. This supports the claim that creatine enters cells through CRTR; the passage does not give a page number. (LLM, conf=0.92)
- Supportedcites [61] Beard E. Braissant O. Synthesis and transport of creatine in the CNS: Importance for cerebral functions J. Neurochem. 2010 115 297 313 10.1111/j.1471-4159.2010.06935.x 20796169 source
The Abstract says cells take up creatine through the specific transporter SLC6A8, also called CRT. The “Creatine metabolism and transport” section identifies SLC6A8 as a plasma-membrane transporter, supporting entry into the cell’s cytosol. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The creatine phosphate shuttle is important in translocating ATP produced from oxidative phosphorylation in the mitochondrial to the cytosol and areas within the cell needing ATP for energy metabolism [50,56,57].”
§ Creatine in Health and Disease > 3. Metabolic Role
What the sources say
- Supportedcites [50] Wallimann T. Tokarska-Schlattner M. Schlattner U. The creatine kinase system and pleiotropic effects of creatine Amino Acids 2011 40 1271 1296 10.1007/s00726-011-0877-3 21448658 PMC3080659 source
The Abstract states that 'The CK/PCr energy shuttle connects sites of ATP production (glycolysis and mitochondrial oxidative phosphorylation) with subcellular sites of ATP utilization (ATPases)', overcoming diffusion limitations of ADP and ATP, and Fig. 1/Fig. 3 (CK isoforms and their molecular structure; Functions of mitochondrial CK) spell out the mitochondrial leg: ATP generated by OP is exported via ANT, trans-phosphorylated to PCr by mtCK and exported via VDAC into the cytosol, then regenerating ATP in situ at ATPases. The citing sentence's 'creatine phosphate shuttle' correctly names the translocating moiety (PCr), so the paraphrase matches the source in population, mechanism and direction; only the wording 'translocating ATP' is a loose rendering of translocating mitochondrial ATP-derived high-energy phosphoryl groups, which the source's own framing (no obligatory diffusion of ATP/ADP) accommodates. (LLM, conf=0.85)
- Not checked yetcites [56] Schlattner U. Klaus A. Rios S.R. Guzun R. Kay L. Tokarska-Schlattner M. Cellular compartmentation of energy metabolism: Creatine kinase microcompartments and recruitment of B-type creatine kinase to specific subcellular sites Amino Acids 2016 48 1751 1774 10.1007/s00726-016-2267-3 27318991 source
- Supportedcites [57] Ydfors M. Hughes M.C. Laham R. Schlattner U. Norrbom J. Perry C.G. Modelling in vivo creatine/phosphocreatine in vitro reveals divergent adaptations in human muscle mitochondrial respiratory control by ADP after acute and chronic exercise J. Physiol. 2016 594 3127 3140 10.1113/JP271259 26631938 PMC4887669 source
The Introduction (passage [1]) describes exactly this mechanism: mtCK in the inner mitochondrial membrane space transfers a phosphate from (oxidatively produced) ATP to Cr, the resulting PCr diffuses to the cytosol ~7-fold faster than ATP, and is dephosphorylated by cytosolic creatine kinases 'at sites of ATP utilization', with Cr returning to the mitochondria ~2000-fold faster than ADP. The same passage states that such 'phosphate shuttling' is 'viewed as a predominant method of energy exchange in muscle', which supports the claim's 'important in translocating'. The paper does not merely credit this to others (Wallimann et al. 2011 and others) but relies on it, since its whole design models in vivo Cr/PCr phosphate-shuttling conditions in vitro (Abstract, passages [4] and [6]). The only wording slack is that the shuttle transfers the high-energy phosphate as PCr rather than ATP itself, which is the standard paraphrase of this model. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While these well-recognized creatine effects benefit the athlete, creatine may also serve as a potential clinical and therapeutic supplementary treatment to conventional medical interventions [2,3,4,5,6,7,8,9,10].”
§ Creatine in Health and Disease > 1. Introduction
What the sources say
- Not checked yetcites [2] Stares A. Bains M. The Additive Effects of Creatine Supplementation and Exercise Training in an Aging Population: A Systematic Review of Randomized Controlled Trials J. Geriatr. Phys. Ther. 2020 43 99 112 10.1519/JPT.0000000000000222 30762623 source
- Not checked yetcites [3] Dolan E. Gualano B. Rawson E.S. Beyond muscle: The effects of creatine supplementation on brain creatine, cognitive processing, and traumatic brain injury Eur. J. Sport Sci. 2019 19 1 14 10.1080/17461391.2018.1500644 30086660 source
- Supportedcites [4] Dolan E. Artioli G.G. Pereira R.M.R. Gualano B. Muscular Atrophy and Sarcopenia in the Elderly: Is There a Role for Creatine Supplementation? Biomolecules 2019 9 642 10.3390/biom9110642 PMC6921011 31652853 source
The Introduction describes growing recognition of creatine’s therapeutic potential. Section 6 says creatine supplementation is most effective as an adjunct to resistance training, which the paper identifies as part of sarcopenia treatment. This supports the hedged claim that creatine may complement established interventions. (LLM, conf=0.88)
- Supportedcites [5] Wallimann T. Riek U. Moddel M. Intradialytic creatine supplementation: A scientific rationale for improving the health and quality of life of dialysis patients Med. Hypotheses 2017 99 1 14 10.1016/j.mehy.2016.12.002 28110688 source
The section on inflammatory markers and homocysteine describes creatine as a possible adjuvant therapeutic intervention for type 2 diabetes. The Hypotheses section also proposes its supplementation for patients with CKD, while the Conclusions call for clinical studies to test that proposal. These passages support the claim's cautious wording that creatine may serve as a supplementary clinical treatment; page numbers were not supplied. (LLM, conf=0.91)
- Supportedcites [6] Riesberg L.A. Weed S.A. McDonald T.L. Eckerson J.M. Drescher K.M. Beyond muscles: The untapped potential of creatine Int. Immunopharmacol. 2016 37 31 42 10.1016/j.intimp.2015.12.034 26778152 PMC4915971 source
The Conclusions describe potential uses for creatine in clinical settings, and the Introduction frames dietary creatine supplementation as a possible way to modulate disease. The Parkinson’s disease section also discusses creatine in patients receiving dopaminergic therapy. These passages support the cautiously worded claim of a potential supplementary treatment, not an established clinical benefit. (LLM, conf=0.85)
- Not checked yetcites [7] Ellery S.J. Walker D.W. Dickinson H. Creatine for women: A review of the relationship between creatine and the reproductive cycle and female-specific benefits of creatine therapy Amino Acids 2016 48 1807 1817 10.1007/s00726-016-2199-y 26898548 source
- Supportedcites [8] Smith R.N. Agharkar A.S. Gonzales E.B. A review of creatine supplementation in age-related diseases: More than a supplement for athletes F1000Research 2014 3 222 10.12688/f1000research.5218.1 25664170 PMC4304302 source
The 'Physiological creatine concentrations and creatine supplementation' section says creatine use has expanded beyond athletics to treating several medical conditions. The Conclusions describe ongoing clinical trials and potential therapeutic uses. Together, these support the qualified claim that creatine may serve as a supplementary clinical treatment; the paper does not present it as an established replacement for conventional care. (LLM, conf=0.90)
- Not checked yetcites [9] Candow D.G. Chilibeck P.D. Forbes S.C. Creatine supplementation and aging musculoskeletal health Endocrine 2014 45 354 361 10.1007/s12020-013-0070-4 24190049 source
- Not checked yetcites [10] Gualano B. Roschel H. Lancha A.H. Jr. Brightbill C.E. Rawson E.S. In sickness and in health: The widespread application of creatine supplementation Amino Acids 2012 43 519 529 10.1007/s00726-011-1132-7 22101980 source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“This is because creatine plays a critical role in cellular metabolism, particularly during metabolically stressed states, and limitations in the ability to transport and/or store creatine can impair metabolism.”
- Also stated in: § 3. Metabolic Role · plain
“Creatine and phosphagens play a critical role in providing energy through the creatine kinase (CK) and PCr system [50,54,55].”
§ Creatine in Health and Disease > Abstract
What the sources say
- Supportedcites [50] Wallimann T. Tokarska-Schlattner M. Schlattner U. The creatine kinase system and pleiotropic effects of creatine Amino Acids 2011 40 1271 1296 10.1007/s00726-011-0877-3 21448658 PMC3080659 source
The Abstract describes the creatine kinase/phosphocreatine system as an energy buffer, transport system and metabolic regulator, particularly in tissues with fluctuating energy demands. The “Temporal and spatial energy buffering” section reports that cells with the creatine-producing system maintained ATP levels during metabolic stress; it also describes creatine transport into cells and storage as phosphocreatine. (LLM, conf=0.91)
- Not checked yetcites [54] Wallimann T. Schlosser T. Eppenberger H.M. Function of M-line-bound creatine kinase as intramyofibrillar ATP regenerator at the receiving end of the phosphorylcreatine shuttle in muscle J. Biol. Chem. 1984 259 5238 5246 10.1016/S0021-9258(17)42981-4 6143755 source
- Not checked yetcites [55] Wallimann T. Dolder M. Schlattner U. Eder M. Hornemann T. O’Gorman E. Ruck A. Brdiczka D. Some new aspects of creatine kinase (CK): Compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology Biofactors 1998 8 229 234 10.1002/biof.5520080310 9914824 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3. Metabolic Role · plain
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Creatine supplementation has been reported to increase muscle creatine and PCr levels, enhance acute exercise capacity, and improve training adaptations [44,66,69,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96].”
§ Creatine in Health and Disease > 4. General Health Benefits
What the sources say
- Supportedcites [44] Buford T.W. Kreider R.B. Stout J.R. Greenwood M. Campbell B. Spano M. Ziegenfuss T. Lopez H. Landis J. Antonio J. International Society of Sports Nutrition position stand: Creatine supplementation and exercise J. Int. Soc. Sports Nutr. 2007 4 6 10.1186/1550-2783-4-6 17908288 PMC2048496 source
The review’s “Supplementation Protocols and Effects on Muscle Creatine Stores” section reports a 10–40% increase in muscle creatine and PCr stores with a creatine-loading protocol. Its “Effects of Supplementation on Exercise Performance and Training Adaptations” section also reports increased muscle creatine and PCr content with longer-term supplementation and training. (LLM, conf=0.95)
- Not checked yetcites [66] Tarnopolsky M.A. Potential benefits of creatine monohydrate supplementation in the elderly Curr. Opin. Clin. Nutr. Metab. Care 2000 3 497 502 10.1097/00075197-200011000-00013 11085837 source
- Not checked yetcites [69] Rawson E.S. Venezia A.C. Use of creatine in the elderly and evidence for effects on cognitive function in young and old Amino Acids 2011 40 1349 1362 10.1007/s00726-011-0855-9 21394604 source
- Not checked yetcites [72] Cornish S.M. Chilibeck P.D. Burke D.G. The effect of creatine monohydrate supplementation on sprint skating in ice-hockey players J. Sports Med. Phys. Fit. 2006 46 90 98 16596105
- Not checked yetcites [73] Dawson B. Vladich T. Blanksby B.A. Effects of 4 weeks of creatine supplementation in junior swimmers on freestyle sprint and swim bench performance J. Strength Cond. Res. 2002 16 485 490 12423175
- Not checked yetcites [74] Grindstaff P.D. Kreider R. Bishop R. Wilson M. Wood L. Alexander C. Almada A. Effects of creatine supplementation on repetitive sprint performance and body composition in competitive swimmers Int. J. Sport Nutr. 1997 7 330 346 10.1123/ijsn.7.4.330 9407259 source
- Not checked yetcites [75] Juhasz I. Gyore I. Csende Z. Racz L. Tihanyi J. Creatine supplementation improves the anaerobic performance of elite junior fin swimmers Acta Physiol. Hung. 2009 96 325 336 10.1556/APhysiol.96.2009.3.6 19706374 source
- Not checked yetcites [76] Silva A.J. Machado Reis V. Guidetti L. Bessone Alves F. Mota P. Freitas J. Baldari C. Effect of creatine on swimming velocity, body composition and hydrodynamic variables J. Sports Med. Phys. Fit. 2007 47 58 64 17369799
- Not checked yetcites [77] Kreider R.B. Ferreira M. Wilson M. Grindstaff P. Plisk S. Reinardy J. Cantler E. Almada A.L. Effects of creatine supplementation on body composition, strength, and sprint performance Med. Sci. Sports Exerc. 1998 30 73 82 10.1097/00005768-199801000-00011 9475647 source
- Not checked yetcites [78] Stone M.H. Sanborn K. Smith L.L. O’Bryant H.S. Hoke T. Utter A.C. Johnson R.L. Boros R. Hruby J. Pierce K.C. Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players Int. J. Sport Nutr. 1999 9 146 165 10362452 source
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
69 more claims · 15 with their cited sources checked
Create a free account to see all 124 claims and to verify the 263 references still open.
- It may state two separate claims as one. 45
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although creatine is widely used for performance enhancement in sports, existing literature primarily emphasizes performance-related outcomes and frequently extrapolates adult findings to younger populations, with limited focus on clinically relevant considerations such as safety monitoring, dosing strategies, and patient counseling [3,9,10].”
From Evaluating the Safety of Creatine Monohydrate in Adolescents: A Systematic Review of Renal, Hepatic, and Cardiometabolic Outcomes (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While several narrative reviews and expert position statements have addressed creatine supplementation in youth, few have systematically synthesized safety-related outcomes specifically within adolescent and physically active pediatric populations using contemporary evidence [9-11].”
From Evaluating the Safety of Creatine Monohydrate in Adolescents: A Systematic Review of Renal, Hepatic, and Cardiometabolic Outcomes (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CrM is the gold standard to compare other purported forms of creatine due to its known bioavailability, pharmacokinetics, efficacy, and safety [5,14,15,25,62].”
From Bioavailability, Efficacy, Safety, and Regulatory Status of Creatine and Related Compounds: A Critical Review (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For a dietary source of creatine to be bioavailable, creatine must be: (1) absorbed as creatine into the blood and transported to tissues [2,25]; (2) transported into tissue via tissue-specific creatine transporter genes (e.g., CRT1 or SLC6A8 in muscle) [6,7]; and (3) increase tissue and cellular creatine and PCr content by a physiologically meaningful amount to influence metabolic activity (e.g.,”
From Bioavailability, Efficacy, Safety, and Regulatory Status of Creatine and Related Compounds: A Critical Review (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Given the health benefits of creatine, availability of ineffective sources of creatine or recommendations to take less creatine than needed to increase creatine stores in the muscle and/or brain can limit the benefits theses populations may derive from creatine supplementation [5].”
From Bioavailability, Efficacy, Safety, and Regulatory Status of Creatine and Related Compounds: A Critical Review (2022) · cites this paper as [5]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
Thomas, D. T., Erdman, K. A., & Burke, L. M. (2016) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2015.12.006 · Cited by 1,359
Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
Harris, R. C., Söderlund, K., & Hultman, E. (1992) · Clinical Science · doi:10.1042/cs0830367 · Cited by 1,168 · cited 2×
“However, some studies have shown that consuming 2–3 g/day of creatine for 30 days can also effectively increase muscle creatine stores [46,49].”
BackgroundKreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057 · cited 9×
“Creatine supplementation is one of the most studied and effective ergogenic aids for athletes [1].”
BackgroundInfluentialSelf-citationISSN exercise & sports nutrition review update: research & recommendations
Kerksick, C. M., Wilborn, C. D., Roberts, M. D., Smith-Ryan, A., Kleiner, S. M., Jäger, R., Collins, R., Cooke, M., Davis, J. N., Galvan, E., et al. (2018) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-018-0242-y · Cited by 945 · cited 3×
“The remaining amount of creatine needed to maintain normal tissue levels of creatine is obtained in the diet primarily from red meat and fish [38–41] or dietary supplements [1,42,43].”
BackgroundSelf-citation(2009) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2009.01.005 · Cited by 912
Muscle creatine loading in men
Hultman, E., Soderlund, K., Timmons, J. A., Cederblad, G., & Greenhaff, P. L. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.1.232 · Cited by 822
The creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
AAEM minimonograph #26: The electrodiagnosis of carpal tunnel syndrome
Stevens, J. C. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199712)20:12 · Cited by 518
Research works printed but not linked: 2
- Mercimek-Mahmutoglu S. Salomons G.S. Creatine Deficiency Syndromes GeneReviews(R) Pagon R.A. Adam M.P. Ardinger H.H. Wallace S.E. Amemiya A. Bean L.J.H. Bird T.D. Ledbetter N. Mefford H.C. Smith R.J.H. University of Washington Seattle, WA, USA 1993 20301745
- Rawson E.S. The safety and efficacy of creatine monohydrate supplementation Sport Sci. Exch. 2018 29 1 6
Cited by
Metabolic Basis of Creatine in Health and Disease: A Bioinformatics-Assisted Review
Bonilla, D. A., Kreider, R. B., Stout, J. R., Forero, D. A., Kerksick, C. M., Roberts, M. D., & Rawson, E. S. (2021) · Nutrients · doi:10.3390/nu13041238 · Cited by 223
“Readers are encouraged to refer to the outstanding invited reviews of this book/special issue on “Creatine Supplementation for Health and Clinical Diseases” to learn more about the effects of CrM supplementation [48].”
BackgroundSelf-citationEffects of creatine supplementation on brain function and health
Forbes, S. C., Cordingley, D. M., Cornish, S. M., Gualano, B., Roschel, H., Ostojic, S. M., Rawson, E. S., Roy, B. D., Prokopidis, K., Giannos, P., et al. (2022) · Nutrients · doi:10.3390/nu14050921 · Cited by 145
Kreider, R. B., Jäger, R., & Purpura, M. (2022) · Nutrients · doi:10.3390/nu14051035 · Cited by 103
“A recent Special Issue on creatine supplementation for health and clinical diseases overviewed the metabolic basis of creatine in health and disease [5] and potential health and/or therapeutic benefits of CrM supplementation for pregnancy and newborn health [146], children and adolescents [147–151], physically active…”
BackgroundInfluentialSelf-citationSong, J., Zhang, Y., Zhu, Y., Jin, X., Li, L., Wang, C., Zhou, Y. M., Li, Y., Wang, D., & Hu, M. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.120601 · Cited by 103
“Heads up” for creatine supplementation and its potential applications for brain health and function
Candow, D. G., Forbes, S. C., Ostojic, S. M., Prokopidis, K., Stock, M. S., Harmon, K. K., & Faulkner, P. (2023) · Sports Medicine · doi:10.1007/s40279-023-01870-9 · Cited by 78
Metadata
- Authors
- Kreider, R. B., & Stout, J. R.
- Affiliations
- Texas A&M University (US)
- Physiology of Work and Exercise Response (POWER) Laboratory, Institute of Exercise Physiology and Rehabilitation Science, School of Kinesiology and Physical Therapy, University of Central Florida, 12494 University Blvd., Orlando, FL 32816, USA
- Corresponding author
- Kreider, Richard B.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2021-01-29
- Volume
- 13
- Issue
- 2
- Pages
- 447
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7910963
- OpenAlex
- W3128849795
- Semantic Scholar
- 8533d87570b0270506b648d326c4b0ffec2c0787
- Cited by
- 227
- References
- 337
- Citations by year
- 2026: 48 · 2025: 58 · 2024: 39 · 2023: 39 · 2022: 22 · 2021: 21
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- creatine, creatine supplementation, ergogenic aids, cellular metabolism, injury recovery, chronic disease management, aging, physical activity, hypoxia
- MeSH terms
- Aging, Biological Availability, Chronic Disease, Creatine, Humans, Wounds and Injuries, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Creatine in Health and Disease. https://app.cochat.ai/papers/10.3390/nu13020447
- The paper
- Kreider, R. B., & Stout, J. R. (2021). Creatine in Health and Disease. Nutrients. https://doi.org/10.3390/nu13020447
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.